tiprankstipranks
Advertisement
Advertisement

ACAD Stock Latest News

Acadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital
The FlyAcadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital
4d ago
ACAD
Acadia Pharmaceuticals appoints Carl Segerstorm as CPO
PremiumThe Fly
Acadia Pharmaceuticals appoints Carl Segerstorm as CPO
5d ago
ACAD
Acadia Pharmaceuticals price target raised to $30 from $29 at BofA
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $30 from $29 at BofA
11d ago
ACAD
EU’s CHMP reverses course on Acadia’s trofinetide, says H.C. Wainwright
PremiumThe Fly
EU’s CHMP reverses course on Acadia’s trofinetide, says H.C. Wainwright
12d ago
ACAD
Acadia Pharmaceuticals price target raised to $37 from $32 at Deutsche Bank
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $37 from $32 at Deutsche Bank
12d ago
ACAD
Acadia Pharmaceuticals price target raised to $36 from $32 at Canaccord
PremiumThe FlyAcadia Pharmaceuticals price target raised to $36 from $32 at Canaccord
12d ago
ACAD
Citi adds ‘upside 90-day catalyst watch’ on Acadia Pharmaceuticals
Premium
The Fly
Citi adds ‘upside 90-day catalyst watch’ on Acadia Pharmaceuticals
13d ago
ACAD
Acadia Pharmaceuticals price target raised to $35 from $32 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target raised to $35 from $32 at Citi
13d ago
ACAD
Buy Rating Reiterated on ACADIA as EU Rett Prospects Strengthen; $37 Price Target Unchanged
PremiumRatings
Buy Rating Reiterated on ACADIA as EU Rett Prospects Strengthen; $37 Price Target Unchanged
15d ago
ACAD
Acadia Pharmaceuticals rises 13.4%
PremiumThe Fly
Acadia Pharmaceuticals rises 13.4%
15d ago
ACAD
Midday Fly By: On Semi to acquire Synaptics, OpenAI leans toward 2027 IPO
PremiumThe Fly
Midday Fly By: On Semi to acquire Synaptics, OpenAI leans toward 2027 IPO
15d ago
BA
GS
Acadia Pharmaceuticals Stock (ACAD) Jumps on a Positive CHMP Review
PremiumMarket News
Acadia Pharmaceuticals Stock (ACAD) Jumps on a Positive CHMP Review
15d ago
ACAD
Acadia Pharmaceuticals rises 9.9%
PremiumThe FlyAcadia Pharmaceuticals rises 9.9%
15d ago
ACAD
Acadia Pharmaceuticals: Daybu recommended for approval in EU by CHMP
Premium
The Fly
Acadia Pharmaceuticals: Daybu recommended for approval in EU by CHMP
15d ago
ACAD
Acadia Shareholders Approve Directors, Executive Pay and Equity Plan
Premium
Company Announcements
Acadia Shareholders Approve Directors, Executive Pay and Equity Plan
1M ago
8K
ACAD
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
2M ago
ACAD
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call
PremiumCompany Announcements
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call
2M ago
ACAD
ACADIA: Buy Rating Reiterated on Durable Commercial Strength and Pipeline Catalysts; $37 Price Target Maintained
PremiumRatings
ACADIA: Buy Rating Reiterated on Durable Commercial Strength and Pipeline Catalysts; $37 Price Target Maintained
2M ago
ACAD
ACADIA: Buy Rating Reiterated on Nuplazid/Daybue Upside and Remlifanserin Optionality; $32 DCF-Based Price Target Maintained
PremiumRatings
ACADIA: Buy Rating Reiterated on Nuplazid/Daybue Upside and Remlifanserin Optionality; $32 DCF-Based Price Target Maintained
2M ago
ACAD
Acadia Pharmaceuticals reports Q1 EPS 2c, consensus 8c
PremiumThe FlyAcadia Pharmaceuticals reports Q1 EPS 2c, consensus 8c
2M ago
ACAD
Acadia Pharmaceuticals backs FY26 revenue view $1.22B-$1.28B, consensus $1.25B
Premium
The Fly
Acadia Pharmaceuticals backs FY26 revenue view $1.22B-$1.28B, consensus $1.25B
2M ago
ACAD
Is ACAD a Buy, Before Earnings?
Premium
Pre-Earnings
Is ACAD a Buy, Before Earnings?
2M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >